Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
about
Vascular Remodelling and Mesenchymal Transition in Systemic SclerosisControl of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface DiseasesUpdate on mesenchymal stem cell-based therapy in lupus and sclerodermaBottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal CellsIntrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic SclerosisTherapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells.Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitisCirculating progenitor cells and sclerodermaImpaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.Coagulation and autoimmunity in scleroderma interstitial lung disease.Multipotent Mesenchymal Stromal Cells for Autoimmune DiseasesFibrin-based 3D matrices induce angiogenic behavior of adipose-derived stem cells.Vascular involvement in systemic sclerosis (scleroderma).Pathogenesis of Systemic Sclerosis.Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic DiseasesToward an in vitro vasculature: differentiation of mesenchymal stromal cells within an endothelial cell-seeded modular construct in a microfluidic flow chamber.Management of massive soft tissue defects: The use of INTEGRA® artificial skin after necrotizing soft tissue infection of the chest.Application potential of bone marrow mesenchymal stem cell (BMSCs) based tissue-engineering for spinal cord defect repair in rat fetuses with spina bifida aperta.S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cellsTreatment of systemic sclerosis: potential role for stem cell transplantation.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Mechanisms of vascular damage in SSc--implications for vascular treatment strategies.Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta.Genistein protects dermal fibrosis in bleomycin-induced experimental sclerodermaMechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicine.Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.The pathogenesis of systemic sclerosis revisited.Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases.Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review.Review: evidence that systemic sclerosis is a vascular disease.Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis.Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells isolated from experimental autoimmune encephalomyelitis mice.Angiogenin and SDF-1α serum concentration in patients with systemic sclerosis in relation to clinical status.Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.Expression of transforming growth factor β receptor II in mesenchymal stem cells from systemic sclerosis patientsThe vascular microenvironment and systemic sclerosis.
P2860
Q26749091-881E187D-D2CF-4EED-A123-C40480113841Q26750660-E0A1E0DA-5427-40D9-9F01-F4316A523928Q26777402-A89E7742-AA7B-42FA-906B-CB22988BEE1BQ26798278-3D5586B3-C10E-4B5F-B4F1-30BC9F79083CQ28551230-FEDFA9CF-8527-43A1-A829-A17A6CD1F607Q33532670-7CDAD4EE-E355-4624-ABCF-597EDBDFB046Q33898618-99CE5A8F-2E17-4569-BDDF-376589F2DF27Q33989134-BE93733E-5604-405D-9BF6-8722B7E16400Q34389943-9CD909BF-EC51-4DCD-8DC3-4F5571C57114Q34770486-882C97AF-F050-4B05-BCF2-DF7583463E96Q34791234-0EB1C245-6A89-4781-B30B-ABDC08C02C3FQ35235945-43806BC9-4F7C-4EAD-B24F-36373D3F8913Q35557424-8CB389B3-E7A2-4F71-8476-5A853A45A50FQ35693212-FF8DA34F-3672-4FC4-BC4F-CE8A9A1F96ACQ35750457-8DD6F9EA-4B2B-4F95-AAD2-B5FA9CDF579EQ35855711-7D3E092F-084C-4198-AB2D-77C3E4EC25A8Q36042254-876337F6-7900-438A-99A8-FEDC8D279F18Q36599535-220FD158-0566-4326-B3DF-AB9294288B3BQ36637366-7601C209-8211-4AB7-B90A-C3D8F2049250Q37194001-5413C843-B2D3-448D-BB72-5931239C285FQ37224668-1652C7F7-54C3-4425-8D6C-AB2C8F1C82CAQ37265800-D14FC0F3-2A30-4222-B098-005EE9A33973Q37295556-F2FFDDB6-4F1C-4519-99D0-99BA5ABDA7D8Q37305174-DCD35F32-AF61-40ED-B17E-7E4AB587D70EQ37310583-13FD5B52-263C-4F20-B44F-19251BC22B4AQ37630934-ED1E200F-FFB3-43EB-9657-E2E4A48754F0Q37635275-3C68FB29-9422-4752-B6F8-8572637A433CQ37678280-9835B152-34B3-42DF-B79B-69F2E0EF26FBQ37768336-4C1F255E-7766-438D-80D0-83CFDD3E2DD9Q37885846-089E133D-B295-4C5E-9AA7-661A32D7DF8BQ38072387-3C3BF276-E3EE-443F-BE94-BC1DD647A63DQ38105984-1BDDC5DD-8B3B-4931-9EAB-72518A274BB9Q38283226-B025D60B-D953-49A4-9DDD-58EFCBABACE7Q38840236-32F69535-F6F4-4DF7-B84D-F462B656C013Q39444572-A92E05C0-2F90-4905-8294-2031F0B965E3Q40413712-31D76443-9291-451D-9B95-DB6BAB32CEE5Q40528423-CC9CB5EF-A40A-4FF9-A54C-4FAAE3126F4CQ41196008-814485D1-5A0E-4C99-8994-4E293F683556Q41790850-04B2E951-9507-4498-ABFD-2A0AC23DF5F6Q41863950-6794F326-619D-4911-B1E6-34380804BFC4
P2860
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Impairment of endothelial cell ...... genesis of systemic sclerosis.
@en
Impairment of endothelial cell ...... genesis of systemic sclerosis.
@nl
type
label
Impairment of endothelial cell ...... genesis of systemic sclerosis.
@en
Impairment of endothelial cell ...... genesis of systemic sclerosis.
@nl
prefLabel
Impairment of endothelial cell ...... genesis of systemic sclerosis.
@en
Impairment of endothelial cell ...... genesis of systemic sclerosis.
@nl
P2093
P50
P356
P1476
Impairment of endothelial cell ...... genesis of systemic sclerosis.
@en
P2093
A Marrelli
R Saccardi
S Guiducci
P304
P356
10.1002/ART.22698
P577
2007-06-01T00:00:00Z